Equities
Health CareMedical Equipment and Services
  • Price (JPY)2,531.00
  • Today's Change-16.00 / -0.63%
  • Shares traded1.73m
  • 1 Year change-2.37%
  • Beta0.8868
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

ASAHI INTECC CO., LTD. is a Japan-based company engaged in the manufacture and sale of products in the medical device field and industrial device field. The Company operates through two business segments. The Medical segment is engaged in the development, manufacture and sale of private label products and OEM products in the medical device field. The Device segment is engaged in the development, manufacture, and sale of components in the medical device field and industrial device field.

  • Revenue in JPY (TTM)124.90bn
  • Net income in JPY15.16bn
  • Incorporated1976
  • Employees9.47k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PHC Holdings Corp361.11bn5.83bn137.49bn9.04k23.810.93594.220.380845.5745.572,840.851,159.260.6873.495.6039,940,820.001.070.1061.980.161745.5846.911.560.17380.31982.070.6291916.512.175.81181.3214.73-1.83--
Hogy Medical Co Ltd37.84bn222.00m150.09bn1.41k644.371.9326.503.9710.3410.341,754.863,454.270.39192.752.8726,856,640.000.22993.510.25233.8632.3037.880.58679.384.1460.780.140457.350.09721.00-45.79-22.76-12.153.92
Mani Inc30.14bn4.94bn167.89bn4.14k31.282.8322.535.5750.1650.16305.99555.200.51561.6110.587,280,435.008.4510.449.0711.1964.6163.2116.4021.956.27--0.001261.755.1014.54-26.146.8831.5612.13
As One Corp107.58bn8.97bn176.55bn731.0018.732.4416.361.64125.12125.121,500.44959.871.126.053.11147,174,000.009.387.8112.6210.7230.4230.598.348.062.24--0.072751.928.608.079.726.64-16.129.16
Nakanishi Inc79.17bn6.68bn206.85bn2.18k28.151.5616.442.6179.6779.67940.771,437.360.51031.349.4336,317,600.004.3011.225.1012.7256.8860.298.4422.942.77--0.181530.4229.0616.82-62.383.8529.3211.63
Ship Healthcare Holdings Inc701.58bn15.02bn247.43bn7.81k16.421.6711.050.3527159.74159.747,463.691,574.141.9419.806.1489,888,790.004.173.657.777.009.7010.412.152.251.20--0.171633.317.496.969.715.091.879.11
Nipro Corp649.95bn10.89bn247.59bn39.17k24.800.98563.190.380958.2258.223,637.241,465.050.55861.794.1616,593,930.001.071.111.731.7130.2629.841.922.010.83238.180.681942.899.857.81-53.97--5.7413.12
Nihon Kohden Corp230.96bn12.37bn295.94bn6.11k22.871.6316.591.2875.6975.691,415.011,062.470.93691.813.8837,775,760.005.048.436.5411.0851.8851.545.388.492.31--0.12928.591.554.03-17.207.4319.3912.12
Fukuda Denshi Co Ltd138.47bn17.96bn329.16bn3.47k13.581.3111.192.38642.29642.294,964.156,648.580.6513.954.0939,962,190.008.448.579.8010.6354.0050.2812.9712.343.32--0.009829.45-0.93780.8279-0.470814.13-0.247916.80
Alfresa Holdings Corporation3.03tn24.85bn487.62bn12.45k18.860.949512.180.1607135.13135.1316,570.752,684.482.0416.434.55243,692,400.001.702.054.585.337.167.170.83331.021.02--0.057942.103.591.87-7.34-7.42-0.43934.73
ASAHI INTECC CO., LTD.124.90bn15.16bn675.80bn9.47k45.22--27.095.4156.3256.32461.69--------13,184,740.00--8.09--9.5168.1766.0212.1913.78--58.58--35.6011.6016.24-19.436.77-2.4722.43
Sysmex Corp498.69bn46.69bn939.18bn10.53k19.931.9310.531.8874.8874.88799.79774.340.77472.713.4647,345,580.007.238.708.6810.9452.7952.479.3310.982.4915.420.116338.1110.2110.998.129.0013.545.92
Olympus Corp977.65bn97.72bn2.07tn29.30k21.442.8112.632.1286.7087.01867.67662.120.71071.625.4633,370,410.007.106.749.599.5167.2266.8510.0010.691.3524.510.241721.136.535.72342.6914.22-0.219414.87
Data as of Feb 06 2026. Currency figures normalised to Asahi Intecc Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

25.37%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 30 Jun 202512.03m4.53%
Asset Management One Co., Ltd.as of 30 May 20259.81m3.70%
Nomura Asset Management Co., Ltd.as of 08 Jan 20268.40m3.17%
The Vanguard Group, Inc.as of 07 Jan 20267.51m2.83%
Amova Asset Management Co., Ltd.as of 30 Apr 20256.58m2.48%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Apr 20256.56m2.47%
Goldman Sachs Asset Management Co., Ltd. (Japan)as of 30 Sep 20254.28m1.61%
BlackRock Japan Co. Ltd.as of 31 May 20244.16m1.57%
BlackRock Fund Advisorsas of 31 May 20244.05m1.53%
Goldman Sachs Asset Management Internationalas of 30 Sep 20253.90m1.47%
More ▼
Data from 30 Sep 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.